Tribog 2mg/500mg/0.2mg Tablet SR
Marketer
Wells Biosciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Tribog 2mg/500mg/0.2mg Tablet SR
Diabex Trio 2mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, effectively regulating blood glucose. Diabex Trio should be ingested with meals, consistently at the same time daily for optimal results. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to hyperglycemia, increasing the risk of complications like nephropathy, retinopathy, neuropathy, and limb amputation. Remember, this medication is part of a comprehensive diabetes management plan, incorporating a balanced diet, regular physical activity, and weight management as advised by your healthcare provider. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect. Learn to recognize its symptoms—sweating, dizziness, headache, tremor—and how to treat it. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential preventative measures. Alcohol consumption should be limited due to its hypoglycemic effect. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their doctor before initiating treatment. Consult your physician before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.
Primary Ingredients of Tribog 2mg/500mg/0.2mg Tablet SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Tribog 2mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Tribog 2mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Tribog 2mg/500mg/0.2mg Tablet SR. This medication should be swallowed whole; do not break, crush, or chew. Administer on an empty stomach.
Common Side effects of Tribog 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Tribog 2mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Tribog 2mg/500mg/0.2mg Tablet SR on an empty stomach.
How Tribog 2mg/500mg/0.2mg Tablet SR works:
Extended-release Tribog tablets (2mg/500mg/0.2mg) contain a triple combination of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Tribog 2mg/500mg/0.2mg SR tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Extended-release Tribog tablets (2mg/500mg/0.2mg) may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Tribog 2mg/500mg/0.2mg tablet is likely not safe for use while breastfeeding. Preliminary human evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Tribog 2mg/500mg/0.2mg SR tablets is likely unsafe for individuals with kidney impairment and should be avoided. Patients with severe kidney disease should not take Tribog 2mg/500mg/0.2mg SR tablets; medical advice is recommended.
LiverCAUTION
Patients with liver impairment should use Tribog 2mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. Individuals with mild to moderate hepatic dysfunction may begin on a reduced dose; however, its use is contraindicated in those with severe liver disease. Medical advice is essential.
What if you forget to take Tribog 2mg/500mg/0.2mg Tablet SR :
Should you forget to take your Tribog 2mg/500mg/0.2mg SR Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tribog 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Medication |
3,018 People bought this recently